Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy
1996

Drug Resistance and Quercetin in Cancer Treatment

publication Evidence: moderate

Author Information

Author(s): G Sliutzl, J Karlseder, C Tempfer, L Orel, G Holzer, MM Simon

Primary Institution: University of Vienna, Medical School

Hypothesis

Does hsp70 overexpression confer resistance to topotecan and gemcitabine, and can quercetin sensitize these cells to chemotherapy?

Conclusion

Hsp70 overexpression provides resistance to topotecan and gemcitabine, but quercetin can sensitize these resistant cells to chemotherapy.

Supporting Evidence

  • Hsp70 overexpression was shown to significantly increase cell survival after treatment with topotecan and gemcitabine.
  • Quercetin treatment resulted in a marked decrease in hsp70 levels and increased sensitivity to chemotherapy.
  • Cells overexpressing hsp70 were able to restart proliferation after drug treatment, while control cells could not.

Takeaway

Some cancer cells can survive treatments that usually kill them because they have a special protein called hsp70. A natural substance called quercetin can help make these cells more sensitive to the drugs.

Methodology

The study used stably transfected fibrosarcoma cell lines to assess the impact of hsp70 overexpression on drug resistance and the sensitizing effect of quercetin.

Limitations

The study was conducted in vitro, which may not fully represent in vivo conditions.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication